These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 33907225)
1. Human WRN is an intrinsic inhibitor of progerin, abnormal splicing product of lamin A. Kang SM; Yoon MH; Lee SJ; Ahn J; Yi SA; Nam KH; Park S; Woo TG; Cho JH; Lee J; Ha NC; Park BJ Sci Rep; 2021 Apr; 11(1):9122. PubMed ID: 33907225 [TBL] [Abstract][Full Text] [Related]
2. Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture. Rivera-Torres J; Acín-Perez R; Cabezas-Sánchez P; Osorio FG; Gonzalez-Gómez C; Megias D; Cámara C; López-Otín C; Enríquez JA; Luque-García JL; Andrés V J Proteomics; 2013 Oct; 91():466-77. PubMed ID: 23969228 [TBL] [Abstract][Full Text] [Related]
4. Differential stem cell aging kinetics in Hutchinson-Gilford progeria syndrome and Werner syndrome. Wu Z; Zhang W; Song M; Wang W; Wei G; Li W; Lei J; Huang Y; Sang Y; Chan P; Chen C; Qu J; Suzuki K; Belmonte JCI; Liu GH Protein Cell; 2018 Apr; 9(4):333-350. PubMed ID: 29476423 [TBL] [Abstract][Full Text] [Related]
6. p53 isoforms regulate premature aging in human cells. von Muhlinen N; Horikawa I; Alam F; Isogaya K; Lissa D; Vojtesek B; Lane DP; Harris CC Oncogene; 2018 May; 37(18):2379-2393. PubMed ID: 29429991 [TBL] [Abstract][Full Text] [Related]
7. A conserved splicing mechanism of the LMNA gene controls premature aging. Lopez-Mejia IC; Vautrot V; De Toledo M; Behm-Ansmant I; Bourgeois CF; Navarro CL; Osorio FG; Freije JM; Stévenin J; De Sandre-Giovannoli A; Lopez-Otin C; Lévy N; Branlant C; Tazi J Hum Mol Genet; 2011 Dec; 20(23):4540-55. PubMed ID: 21875900 [TBL] [Abstract][Full Text] [Related]
8. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome. Finley J Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605 [TBL] [Abstract][Full Text] [Related]
10. Coronary artery disease in a Werner syndrome-like form of progeria characterized by low levels of progerin, a splice variant of lamin A. Hisama FM; Lessel D; Leistritz D; Friedrich K; McBride KL; Pastore MT; Gottesman GS; Saha B; Martin GM; Kubisch C; Oshima J Am J Med Genet A; 2011 Dec; 155A(12):3002-6. PubMed ID: 22065502 [TBL] [Abstract][Full Text] [Related]
11. Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome. Kang SM; Yoon MH; Ahn J; Kim JE; Kim SY; Kang SY; Joo J; Park S; Cho JH; Woo TG; Oh AY; Chung KJ; An SY; Hwang TS; Lee SY; Kim JS; Ha NC; Song GY; Park BJ Commun Biol; 2021 Jan; 4(1):5. PubMed ID: 33398110 [TBL] [Abstract][Full Text] [Related]
13. Vascular Smooth Muscle-Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome. Hamczyk MR; Villa-Bellosta R; Gonzalo P; Andrés-Manzano MJ; Nogales P; Bentzon JF; López-Otín C; Andrés V Circulation; 2018 Jul; 138(3):266-282. PubMed ID: 29490993 [TBL] [Abstract][Full Text] [Related]
14. Progerinin, an Inhibitor of Progerin, Alleviates Cardiac Abnormalities in a Model Mouse of Hutchinson-Gilford Progeria Syndrome. Kang SM; Seo S; Song EJ; Kweon O; Jo AH; Park S; Woo TG; Kim BH; Oh GT; Park BJ Cells; 2023 Apr; 12(9):. PubMed ID: 37174632 [TBL] [Abstract][Full Text] [Related]
15. A lamin A protein isoform overexpressed in Hutchinson-Gilford progeria syndrome interferes with mitosis in progeria and normal cells. Cao K; Capell BC; Erdos MR; Djabali K; Collins FS Proc Natl Acad Sci U S A; 2007 Mar; 104(12):4949-54. PubMed ID: 17360355 [TBL] [Abstract][Full Text] [Related]
16. Progerin impairs chromosome maintenance by depleting CENP-F from metaphase kinetochores in Hutchinson-Gilford progeria fibroblasts. Eisch V; Lu X; Gabriel D; Djabali K Oncotarget; 2016 Apr; 7(17):24700-18. PubMed ID: 27015553 [TBL] [Abstract][Full Text] [Related]
17. Targeting the phospholipase A2 receptor ameliorates premature aging phenotypes. Griveau A; Wiel C; Le Calvé B; Ziegler DV; Djebali S; Warnier M; Martin N; Marvel J; Vindrieux D; Bergo MO; Bernard D Aging Cell; 2018 Dec; 17(6):e12835. PubMed ID: 30216637 [TBL] [Abstract][Full Text] [Related]
18. Heterochromatin loss as a determinant of progerin-induced DNA damage in Hutchinson-Gilford Progeria. Chojnowski A; Ong PF; Foo MXR; Liebl D; Hor LP; Stewart CL; Dreesen O Aging Cell; 2020 Mar; 19(3):e13108. PubMed ID: 32087607 [TBL] [Abstract][Full Text] [Related]
19. Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype. Lee SJ; Jung YS; Yoon MH; Kang SM; Oh AY; Lee JH; Jun SY; Woo TG; Chun HY; Kim SK; Chung KJ; Lee HY; Lee K; Jin G; Na MK; Ha NC; Bárcena C; Freije JM; López-Otín C; Song GY; Park BJ J Clin Invest; 2016 Oct; 126(10):3879-3893. PubMed ID: 27617860 [TBL] [Abstract][Full Text] [Related]
20. Hutchinson-Gilford Progeria Syndrome: A premature aging disease caused by LMNA gene mutations. Gonzalo S; Kreienkamp R; Askjaer P Ageing Res Rev; 2017 Jan; 33():18-29. PubMed ID: 27374873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]